← all drugs
Azacitidine Injection
in shortage · Oncology · Snapshot: 2026-08-25
Day 2,076
of this shortage, counting from the FDA's first posting on 12/18/2020
- Manufacturers listed
- Fresenius Kabi USA, LLC, Meitheal Pharmaceuticals, Inc., Dr. Reddy's Laboratories, Inc., Teva Pharmaceuticals USA, Inc., Accord Healthcare Inc., Hikma Pharmaceuticals USA, Inc., Armas Pharmaceuticals Inc, Bristol Myers Squibb Co., Eugia US LLC
- Reported reason(s)
- Demand increase for the drug; Other
- Machine-readable
- JSON for this drug
Presentations (9)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39) | Fresenius Kabi USA, LLC | Unavailable | 08/04/2026 |
| Azacitidine, Injection, 100 mg/30 mL (NDC 71288-115-30) | Meitheal Pharmaceuticals, Inc. | Available | 06/01/2026 |
| Azacitidine, Injection, 100 mg (NDC 43598-305-62) | Dr. Reddy's Laboratories, Inc. | Available | 08/05/2026 |
| Azacitidine, Injection, 100 mg (NDC 68001-313-56) | Teva Pharmaceuticals USA, Inc. | Unavailable | 08/17/2026 |
| Azacitidine, Injection, 100 mg (NDC 16729-306-10) | Accord Healthcare Inc. | Available | 08/17/2026 |
| Azacitidine, Injection, 100 mg/ Vial (NDC 0143-9606-01) | Hikma Pharmaceuticals USA, Inc. | Available | 08/13/2026 |
| Azacitidine, Injection, 100 mg (NDC 72485-201-01) | Armas Pharmaceuticals Inc | Limited Availability | 06/08/2026 |
| Vidaza, Injection, 100 mg (NDC 59572-102-01) | Bristol Myers Squibb Co. | Available | 08/16/2026 |
| Azacitidine, Injection, 100 mg/4 mL (NDC 55150-393-01) | Eugia US LLC | Unavailable | 08/06/2026 |
History
Daily change tracking began 2026-08-25 (index founding). Status flips and availability changes will accumulate here.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.